Omicron BA.2 subvariant less severe than delta, original omicron
Oct 28, 2022
Mortality rates were lower for omicron BA.2 than for the delta variant and omicron B.1.1.529.
FDA OKs Novavax COVID-19 vaccine as first booster shot
Oct 20, 2022
Until now, the protein-based vaccine was only approved as a two-dose primary series.
Amygdala and insula retraining tied to reduction in fatigue with long COVID
Jul 24, 2023
Furthermore, patients randomly assigned to the neuroplasticity program saw significant gains in energy.
Solanezumab does not slow cognitive decline in preclinical Alzheimer’s disease
Jul 19, 2023
The mean change in Preclinical Alzheimer Cognitive Composite score not significantly different at 240 weeks with solanezumab or placebo.
Viral, symptom rebound common after COVID-19 infection
Mar 09, 2023
The incidence of symptom rebound was higher in the nirmatrelvir plus ritonavir treatment group.
Mental health impact of COVID-19 pandemic examined
Oct 18, 2022
In the first two months of the pandemic, depression and anxiety worsened on average; a linear link was seen between worsening symptoms and increasing case numbers.
Adult day services with specialized care have higher proportion with dementia
Jan 25, 2024
42.2% of clients have dementia in adult day services centers providing specialized care versus 22.7% in nonspecialized centers.
Exercise intervention beneficial for healthcare workers
Aug 10, 2023
A 12-week app-based intervention reduced depressive symptoms, burnout and absenteeism.
Avoidable hospital admissions increased with health care disruption
Jul 21, 2023
Those whose access to healthcare was disrupted during COVID-19 have an increased risk for preventable hospital admission.
Study links greater number of chronic pain sites to risk for dementia
Jul 12, 2023
A greater number of chronic pain sites was linked to an increased incident all-cause dementia and Alzheimer’s disease but not vascular and frontotemporal dementia.